Internal Medicine Doctors in Espanola, NM Accepting Medicare

5 Internal Medicine doctors found. Showing 1 - 5

Rajan K Mirchandani, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1010 Spruce St, Espanola Hospital Pmg Clinic, Espanola, NM 87532 Phone: 505-367-0340    Fax: 505-367-4470

William M Ryan, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1010 Spruce St, Espanola Hospital, Espanola, NM 87532 Phone: 505-367-0340    Fax: 505-367-0346

Salvadeeswaran Lakshmi-narayanan, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1010 Spruce St, Espanola, NM 87532 Phone: 505-367-0340    Fax: 505-367-0346

Jorge A Aguilar, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1010 Spruce St, Espanola Hospital, Espanola, NM 87532 Phone: 505-753-7111    Fax: 505-753-4438

Kalu B Long, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1010 Spruce St, Espanola, NM 87532 Phone: 505-753-7111

News Archive

New malaria vaccine is undergoing Phase 1 trials but current results show it provides strong and long-lasting protection

A new malaria vaccine could be the breakthrough in developing an effective and lasting treatment.

TRYTON-LM clinical study enrolls first two patients

Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced the enrollment of the first two patients in TRYTON-LM, a prospective, single-arm study evaluating the feasibility of the Tryton stent in conjunction with Abbott's XIENCE PRIME Everolimus Eluting Coronary Stent System to treat stable patients with complex de novo bifurcation lesions involving the left main coronary artery.

FDA-approved drug eliminates immune cells that destroys hair follicles in people with alopecia areata

Researchers at Columbia University Medical Center (CUMC) have identified the immune cells responsible for destroying hair follicles in people with alopecia areata, a common autoimmune disease that causes hair loss, and have tested an FDA-approved drug that eliminated these immune cells and restored hair growth in a small number of patients.

Greatbatch announces results for fourth quarter and full-year ended 2014

Greatbatch, Inc., today announced results for its fourth quarter and full-year ended January 3, 2014 highlighted by 5% constant currency organic revenue growth for the full year 2013; 12% year over year improvement in adjusted operating income; and 19% improvement in adjusted diluted EPS over 2012.

New review outlines basic principles of dietary treatment

Thanks to screening of newborns and newly developed therapies, the population of patients with inherited metabolic disorders has expanded. As these patients age and enter adulthood, diet therapy will be the mainstay of treatment for their disorders.

Read more Medical News

› Verified 8 days ago